Guardian Pharmacy Services, Inc. (NYSE: GRDN) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $3.2B. The Maz Rating grades it against the other companies in its sector.
Guardian Pharmacy Services, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $50.33, Guardian Pharmacy Services, Inc. trades at 42.5x trailing earnings, 2.2x sales and 11.9x book value, with an EV/EBITDA of 23.9. Over the last twelve months it generated about $1.5B of revenue and $75M of net income. It runs a gross margin of 22.4%, an operating margin of 6.9% and a net margin of 5.1%. It shows return on equity of 31.8%, return on invested capital of 22.6% and a free cash flow yield of 3.0%. On the balance sheet: a debt-to-equity ratio of 0.13 and a current ratio of 1.65. Over the past 52 weeks the share price ranged from $26.34 to $50.80, with a beta of 0.10.
Guardian Pharmacy Services, Inc. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 4 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.